SHOCKWAVE MEDICAL INC (SWAV) 187.32 -2.17 (-1.15%)
187.32 -2.17 (-1.15%)
US82489T1043 - Common Stock - After market: 187.32 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 264.69. This target is 41.3% above the current price.
SWAV was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about SWAV.
In the previous month the buy percentage consensus was at a similar level.
SWAV was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-26 | Piper Sandler | Maintains | Overweight |
| 2023-01-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-12 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2022-11-08 | Wells Fargo | Maintains | Overweight |
| 2022-10-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-06 | Oppenheimer | Downgrade | Perform -> Underperform |
| 2022-08-29 | Piper Sandler | Maintains | Overweight |
| 2022-08-09 | Wells Fargo | Maintains | Overweight |
| 2022-08-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-09 | Piper Sandler | Maintains | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-10 | SVB Leerink | Maintains | Outperform |
| 2022-05-10 | Wells Fargo | Maintains | Overweight |
| 2022-05-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-02-18 | SVB Leerink | Maintains | Outperform |
| 2022-02-18 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-06 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2021-11-09 | SVB Leerink | Maintains | Outperform |
| 2021-11-09 | Wells Fargo | Maintains | Equal-Weight |
| 2021-08-10 | SVB Leerink | Maintains | Outperform |
| 2021-08-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-15 | SVB Leerink | Initiate | Outperform |
| 2021-07-12 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-06-18 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2021-06-07 | Wells Fargo | Maintains | Overweight |
| 2021-05-11 | Wells Fargo | Maintains | Overweight |
| 2021-05-11 | Canaccord Genuity | Maintains | Buy |
| 2021-05-11 | B of A Securities | Upgrade | Neutral -> Buy |
| 2021-05-11 | Morgan Stanley | Maintains | Equal-Weight |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA